Filing Details
- Accession Number:
- 0001104659-12-047933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-06 17:29:31
- Reporting Period:
- 2012-07-03
- Filing Date:
- 2012-07-06
- Accepted Time:
- 2012-07-06 17:29:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1491576 | Tesaro Inc. | TSRO | Pharmaceutical Preparations (2834) | 272249687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184592 | C Beth Seidenberg | C/O Tesaro, Inc. 1000 Winter Street, Suite 3300 Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-03 | 1,816,748 | $0.00 | 1,816,748 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2012-07-03 | 153,695 | $0.00 | 153,695 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2012-07-03 | 204,889 | $13.50 | 2,021,637 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2012-07-03 | 17,333 | $13.50 | 171,028 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2012-07-03 | 6,358,619 | $0.00 | 1,816,748 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2012-07-03 | 537,932 | $0.00 | 153,695 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- Reflects a 1-for-3.5 reverse stock split which became effective prior to the closing of the Issuer's initial public offering.
- The shares are held directly by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV"). The managing member of KPCB XIV is KPCB XIV Associates, LLC ("KPCB XIV Associates"), of which the Reporting Person is a member. The voting and dispositive control over the shares is shares by the members of KPCB XIV Associates. The shares are held for convenience in the name of "KPCB Holdings, Inc. as nominee."
- The Reporting Person disclaims beneficial ownership over all Issuer shares held for convenience in the name of "KPCB Holdings, Inc. as nominee," except to the extent of her pecuniary interest therein and this filing is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
- The shares are held directly by KPCB XIV Founders Fund, LLC ("KPCB XIV Founders"). The managing member of KPCB XIV Founders is KPCB XIV Associates, LLC ("KPCB XIV Associates"), of which the Reporting Person is a member. The voting and dispositive control over the shares is shares by the members of KPCB XIV Associates. The shares are held for convenience in the name of "KPCB Holdings, Inc. as nominee."